100 related articles for article (PubMed ID: 5824923)
1. Drugs and liver disease.
Read AE
Bristol Med Chir J; 1969 Oct; 84(312):199-207. PubMed ID: 5824923
[No Abstract] [Full Text] [Related]
2. Mechanisms and prediction of drug-induced liver disease.
Berthelot P
Gut; 1973 Apr; 14(4):332-9. PubMed ID: 4574904
[No Abstract] [Full Text] [Related]
3. Hepatic reactions to drugs.
Sherlock S
Gut; 1979 Jul; 20(7):634-48. PubMed ID: 488760
[No Abstract] [Full Text] [Related]
4. Modifying effect of 3-amino-1,2,4-triazole on phenobarbital-induced changes in rat liver.
Stenger RJ; Johnson EA
Exp Mol Pathol; 1972 Apr; 16(2):147-57. PubMed ID: 5014078
[No Abstract] [Full Text] [Related]
5. Liver parenchymal cell injury. IX. Phenobarbital potentiation of endoplasmic reticulum denaturation following carbon tetrachloride.
Reynolds ES; Ree HJ; Moslen MT
Lab Invest; 1972 Mar; 26(3):290-9. PubMed ID: 5016046
[No Abstract] [Full Text] [Related]
6. Further observations upon the effects of phenobarbital pretreatment on the hepatotoxicity of carbon tetrachloride.
Stenger RJ; Johnson EA
Exp Mol Pathol; 1971 Apr; 14(2):220-7. PubMed ID: 5549075
[No Abstract] [Full Text] [Related]
7. Increased bilirubin formation from nonhemoglobin sources in rats with disorders of the liver.
Robinson SH
J Lab Clin Med; 1969 Apr; 73(4):668-76. PubMed ID: 5775136
[No Abstract] [Full Text] [Related]
8. [Drug induced liver diseases].
Neuvonen P
Duodecim; 1974; 90(20):1360-5. PubMed ID: 4609745
[No Abstract] [Full Text] [Related]
9. [Enzyme induction therapy of liver diseases].
Hirayama C
Nihon Rinsho; 1971 Oct; 29(10):2264-75. PubMed ID: 4945895
[No Abstract] [Full Text] [Related]
10. [Drug induced liver disease (author's transl)].
Knoblauch M
Ther Umsch; 1978 Sep; 35(9):747-55. PubMed ID: 360476
[No Abstract] [Full Text] [Related]
11. Histochemical and enzymatic studies on bilirubin metabolism in experimental and clinical liver disorders.
Kanie F
Nagoya Med J; 1972 Feb; 17(3):123-44. PubMed ID: 5050755
[No Abstract] [Full Text] [Related]
12. [Drug-induced liver diseases].
Knoblauch M; Lämmli J; Funk C
Gastroenterol Fortbildungskurse Prax; 1975; 5():64-82. PubMed ID: 1225735
[No Abstract] [Full Text] [Related]
13. [Behavior of extra-renal clearance of sodium thiosulfate in biliary stasis from ligature of the common bile duct and liver disease from carbon tetrachloride].
CHIRICO M
Minerva Nefrol; 1956; 3(1):30-3. PubMed ID: 13334137
[No Abstract] [Full Text] [Related]
14. Drug control of steroid metabolism by the hepatic endoplasmic reticulum.
Feuer G
Drug Metab Rev; 1983; 14(6):1119-44. PubMed ID: 6373207
[TBL] [Abstract][Full Text] [Related]
15. Propiomazine protection in CCl 4 hepatic injury. An electron microscopic study.
Sarphie TG; Lockard VG; Arhelger RB; Brunson JG; Wilson ER
Lab Invest; 1972 Jun; 26(6):648-56. PubMed ID: 4402318
[No Abstract] [Full Text] [Related]
16. Thioridazine-induced cholestasis.
Barancik M; Brandborg LL; Albion MJ
JAMA; 1967 Apr; 200(1):69-70. PubMed ID: 6071857
[No Abstract] [Full Text] [Related]
17. Effect of phenobarbital on hepatic transport and excretion of 131 I-rose bengal in children with cholestasis.
Thaler MM
Pediatr Res; 1972 Feb; 6(2):100-10. PubMed ID: 4403062
[No Abstract] [Full Text] [Related]
18. Mechanism of carbon tetrachloride hepatotoxicity. An in vivo study of its molecular basis in rats and monkeys.
Chopra P; Roy S; Ramalingaswami V; Nayak NC
Lab Invest; 1972 Jun; 26(6):716-27. PubMed ID: 4402320
[No Abstract] [Full Text] [Related]
19. Carbon tetrachloride hepatotoxicity: seeing the wood through the trees.
Food Cosmet Toxicol; 1970 Feb; 8(1):87-93. PubMed ID: 5435759
[No Abstract] [Full Text] [Related]
20. [Efficacy of enzyme-inducing agents in experimental tetrachloromethane poisoning].
Saratikov AS; Novozheeva TP; Vengerovskiĭ AI
Eksp Klin Farmakol; 2003; 66(4):47-9. PubMed ID: 14558353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
